Nutex Health (NASDAQ:NUTX) Sets New 12-Month High Following Insider Buying Activity

Shares of Nutex Health Inc. (NASDAQ:NUTX) reached a new 52-week high on Tuesday following insider buying activity. The stock traded as high as $137.32 and last traded at $129.67, with a volume of 212340 shares trading hands. The stock had previously closed at $132.03.

Specifically, CFO Jon Christian Bates bought 1,000 shares of the company’s stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analysts Set New Price Targets

Separately, Maxim Group boosted their price target on shares of Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, April 8th.

Nutex Health Price Performance

The stock has a market cap of $716.82 million, a P/E ratio of -13.81 and a beta of 0.27. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The firm has a 50-day moving average price of $64.12 and a 200-day moving average price of $42.85.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings data on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The business had revenue of $81.30 million during the quarter, compared to the consensus estimate of $81.13 million.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of NUTX. Topline Capital Management LLC purchased a new stake in Nutex Health in the fourth quarter worth about $5,690,000. Essex Investment Management Co. LLC boosted its position in shares of Nutex Health by 45.4% in the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock worth $3,353,000 after purchasing an additional 33,024 shares in the last quarter. American Century Companies Inc. bought a new stake in shares of Nutex Health in the 4th quarter worth approximately $1,362,000. Ancora Advisors LLC purchased a new stake in shares of Nutex Health in the 4th quarter worth approximately $1,334,000. Finally, Truist Financial Corp increased its position in Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock valued at $1,127,000 after buying an additional 6,454 shares in the last quarter. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.